Solara Active Pharma Sciences Fixes April 2, 2026, as Record Date for Final Call on Rights Shares
Solara Active Pharma Sciences Limited has set April 2, 2026, as the record date for its Second & Final call on partly-paid Rights Shares. The company will collect ₹112.50 per share, comprising ₹3 face value and ₹109.50 premium.
This is a procedural announcement related to a past rights issue. The call for payment on partly paid shares is a standard part of the rights issue process and is unlikely to have a significant immediate impact on the company's stock.
The announcement is a routine procedural step regarding a past rights issue and does not contain new financial performance data or strategic shifts that would indicate a positive or negative sentiment.
Solara Active Pharma Sciences Limited has announced that its Rights Issue Committee, in a meeting held on March 24, 2026, approved the making of the Second & Final call of ₹112.50 per equity share for partly-paid Rights Shares.
This call includes ₹3.00 towards face value and ₹109.50 towards securities premium, as per the Letter of Offer dated May 09, 2024. The Rights Issue Committee has fixed Thursday, April 02, 2026, as the Record date. This date will be used to determine the holders of partly paid-up Equity Shares who will receive the call notice for payment.
The Rights Issue Committee meeting commenced at 9:30 AM and concluded at 9:55 AM on March 24, 2026.
What to do with a filing like this
Solara Active Pharma Sciences Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Solara Active Pharma Sciences Limited. Read the original for the full detail.